| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 245,515 | 186,500 | 157,165 | | Cost of Revenue | 88,890 | 62,501 | 50,784 | | | Gross Profit | 156,625 | 123,999 | 106,381 | | | Operating Expenses | | Research Development | 13,777 | 11,350 | 10,166 | | Selling General and Administrative | 70,445 | 53,260 | 45,337 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 72,403 | 59,389 | 50,878 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 924 | 3,614 | 3,306 | | Earnings Before Interest And Taxes | 73,327 | 63,003 | 54,184 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 73,327 | 63,003 | 54,184 | | Income Tax Expense | 27,208 | 22,925 | 20,952 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 46,119 | 40,078 | 33,232 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 46,119 | 40,078 | 33,232 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $46,119 | $40,078 | $33,232 |
|
1.48% Nasdaq 
Income Statement
